HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

AM 6701

a monoacylglycerol lipase inhibitor

Also Known As:

AM-6701; AM6701

Networked: 1 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Tetrazoles: 14
      - AM 6701: 1

Experts

1.	Bahr, Ben A: 1 article (10/2012)
2.	Graves, Emily E: 1 article (10/2012)
3.	Karanian, David A: 1 article (10/2012)
4.	Locklear, Johnathan R: 1 article (10/2012)
5.	Makriyannis, Alexandros: 1 article (10/2012)
6.	Naidoo, Vinogran: 1 article (10/2012)
7.	Nasr, Mahmoud: 1 article (10/2012)
8.	Quizon, Pamela Marie P: 1 article (10/2012)
9.	Shukla, Vidyanand: 1 article (10/2012)
10.	Vadivel, Subramanian K: 1 article (10/2012)

Related Diseases

1.	Seizures (Absence Seizure) 10/01/2012 - "In vivo, AM6701 was also the more effective compound for reducing the severity of KA-induced seizures and protecting against behavioral deficits linked to seizure damage. "
2.	Brain Injuries (Brain Injury) 10/01/2012 - "It is proposed that the influence of AM6701 on FAAH and MAGL exerts a synergistic action on the endocannabinoid system, thereby promoting the protective nature of cannabinergic signaling to offset excitotoxic brain injury."

Related Drugs and Biologics

1.	Endocannabinoids